The global gene expression market size was estimated at USD 13.85 billion in 2023 and is projected to hit around USD 37.35 billion by 2033, growing at a CAGR of 37.35% during the forecast period from 2024 to 2033.
Key Takeaways:
Gene Expression Market Growth
The key factors driving the market include advancements in genomics, the increasing demand for personalized medicine, and the growing prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders. For instance, cancer involves altered gene expression, with the activation or silencing of several proteins significantly affecting cellular activity.In particular, the activation or silencing of genes can drastically alter the overall cellular activity. Therefore, it is essential to activate and increase the expression of specific genes that are not typically expressed in a particular cell.
Gene expression profiling is a method of simultaneously monitoring the activity (or expression) of thousands of genes in order to offer a comprehensive picture of cellular function. For instance, these profiles can indicate which cells are actively dividing or the way the cells react to a specific treatment. Many of these procedures simultaneously measure the entire genome, or all the genes in a particular cell.Expression profiling experiments often involve measuring the relative amount of mRNA expressed in two or more experimental conditions. This is because variable levels of a particular mRNA sequence indicate a modified requirement for the protein that the mRNA codes for, either indicating a pathological situation or a homeostatic response.
Gene expression has emerged as one of the key technologies used in various applications, such as drug discovery and development procedures, clinical diagnostics, biotechnology, microbiology, and others. This method is used more often throughout different stages of the drug discovery process. The development of new methods has been accelerated up by limitations on the use of current technology and the expanding range of applications for the expression of genes expression research.
Western blotting, northern blotting, enzyme-linked immunosorbent assays, PCR technology with an emphasis on quantitative PCR, differential protein display, and DNA sequencing and hybridization arrays technology with a focus on macro arrays and microarrays in facilitating gene expression are a few examples of technological advancements for gene expression.
Gene Expression Market Report Scope
| Report Attribute | Details |
| Market Size in 2024 | USD 15.29 Billion |
| Market Size by 2033 | USD 37.35 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 37.35% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Process, product, capacity, application, technique, region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | QIAGEN; Quest Diagnostics, Inc.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; PerkinElmer, Inc.; Bio-Rad Laboratories; Thermo Fisher Scientific, Inc.; Agilent Technologies; GE Healthcare; Promega Corp.; Luminex Corp.; Takara Bio, Inc.; Danaher Corp.; ELITechGroup; AutoGenomics; Biocartis NV; IntegraGen; Interpace Biosciences, Inc.; Fluidigm Corp. |
Process Insights
CDNA synthesis & conversion accounted for the largest revenue share of 28.18% in 2023, primarily due to the wide range of available kits that cater to diverse research needs, including optimal reaction temperature, the number of reactions, and sample size. Furthermore, the continuous launch of new cDNA synthesis and library preparation kits is expected to drive the growth of this segment.
Data analysis & interpretation is anticipated to register the fastest CAGR growth of 5.8% during the forecast period. This growth can be attributed to significant investments in cancer-related research and the increasing demand for advanced interpretation software for cancer gene expression studies. Various approaches and algorithms are being developed to study gene expression in complex diseases like cancer. For example, projective clustering techniques and ensemble techniques are reported to be used for the integration of cancer gene expression data.
Product Insights
Kits & Reagents accounted for the largest revenue share of 75.12% in 2023. The large share of the segment is attributed to the presence of a high number of companies offering different types of kits & reagents for gene expression. For instance, Agilent Technologies, Inc. offers an extensive range of gene expression microarray kits & reagents. Furthermore, the introduction of advanced products designed for specific applications drives the segment growth.
DNA Chips are anticipated to register the fastest CAGR growth of 5.4% during the forecast period. DNA microarrays are microscope slides with thousands of tiny dots printed in specific locations; every location has a recognized DNA sequence or gene. These slides are often referred to as DNA or gene chips. These chips are frequently used in the analysis of gene expression profiles to detect diseases, biomarkers, and therapeutic responses in the fields of molecular biology, biomedical research, and genomics.
Capacity Insights
High-plex dominated the gene expression market and accounted for the largest revenue share of 65.15% in 2023.It typically involves analyzing a significant number of gene targets, approximately thousands of genes. The high-plex technology in gene expression analysis includes RNA sequencing and microarrays. Furthermore, high-plex analysis reduces hands-on time when compared to qPCR and other conventional technologies. The technique is also highly accurate and simple as it eliminates the requirement of upfront probe validation. The development of spatially resolved, multiplexed digital characterization systems further enhances the segment's growth.
The low- to mid- plex segment, on the other hand, is anticipated to register a lucrative CAGR of 4.6% in the market during the forecast period of 2024 to 2033. Low mid plex measurements involve analyzing a limited number of genes, often in the range of 5-500 targets. These low to mid-plex methods are cost-effective and relatively easy to perform. Researchers use low to mid-plex techniques for hypothesis-driven research, focused studies, or more general exploratory analysis.
Application Insights
The drug discovery & development segment dominated the market and accounted for the largest revenue share of 43.12% in 2023. Gene-expression profiling has evolved into an effective tool for drug discovery for pharmaceutical companies. The effectiveness, toxicity, and other properties of pharmaceuticals are determined by monitoring the activity of a cell's genes in reaction to the drugs. The cost of conventional profiling techniques can reach millions of dollars, making them frequently ineffective.
The clinical diagnostics is anticipated to register the fastest CAGR of 6.2% from 2024 to 2033. This is a due to the increasing use of gene expression analysis and profiling for the rapid and accurate diagnosis of genetic disorders, understanding disease pathology, and monitoring disease progression and response to therapies. Additionally, by examining gene expression patterns, medical personnel can acquire essential details about the molecular causes of diseases, aiding in early detection, precise diagnosis, and the identification of biomarkers.
Technique Insight
The RNA expression accounted for the largest revenue share of 43% in 2023. RNA-sequencing (RNA-seq) is a high-throughput sequencing (HTS) technique that analyzes cDNA transcripts. It is a relatively new technology that has been widely used in clinical studies. In a Differential Gene Expression (DGE) analysis, RNA-seq is most commonly utilized to compare the expression levels of genes and/or transcripts between two or more conditions (i.e., comparison groups). In cancer research, DGE has been essential in assessing biological function, pathogenesis, and biomarker discovery.
On the other hand, Promoter analysis is anticipated to register the fastest CAGR growth of 5.4% during the forecast period. It plays a crucial role in understanding gene expression regulation and identifying the key factors that govern gene activity. Promoter identification is the first step in the computational study that results in the prediction of regulatory factors. Due to relatively high gene density in relation to genome size, this is a relatively simple problem in lower eukaryotes. The application of promoter analysis techniques in various fields includes drug discovery, advancing genetic diseases, and diagnostic development.
Regional Insight
North America dominated the market and accounted for the largest revenue share of 47% in 2023. Rising funding and increasing research & development efforts, especially in the U.S., are responsible for the growth of the gene expression market.In addition, other factors responsible for market growth include rising importance of gene expression studies, government initiatives, and the availability of financing for NGS research.
Asia Pacific is anticipated to register the fastest CAGR of 6.9% during the forecast period in the market owing to the increasing Investments in R&D, presence of large population base in countries such as India and China that provides personalized and research healthcare. Key companies provide various services and products related to gene expression analysis, RNA sequencing, and expression microarrays. Furthermore, Japan is a significant market for gene expression analysis. The country's strong academic institutions, advanced research infrastructure, and well-established biotech sector are driving the market growth.
Key Companies & Market Share Insights
Major players operating across the market are focused on the adoption of strategic initiatives such as mergers, partnerships, acquisitions, etc. For instance, in September 2022, Illumina, Inc. the global leader in DNA sequencing and array-based technologies launched NovaSeq, new production-scale sequencers expand the boundaries that is feasible in genomic medicine by enabling faster, more potent, and more environmentally friendly sequencing. Utilizing ground-breaking new technology, NovaSeq X Plus can generate more than 20,000 whole genomes annually - 2.5 times the throughput of earlier sequencers - significantly boosting genomic discovery and clinical insights to comprehend disease and eventually alter patient lives.
Also in January 2023, QIAGEN Digital Insights (QDI), launched the QIAGEN CLC Genomics Workbench Premium, which addresses the issue of next-generation sequencing's data-analysis bottleneck. By integrating high analysis speed with the analysis and interpretation of the data from whole exome sequencing (WES), whole genome sequencing (WGS), and large panel sequencing, it is possible to address the bottleneck of the NGS data analysis. Some prominent players in the gene expression market are:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Gene Expression market.
By Process
By Product
By Capacity
By Application
By Technique
By Region
Chapter 1. Gene Expression Market: Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. nova one advisor Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Gene Expression Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Gene Expression Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological advances that enhance gene expression
3.2.1.2. High investment in genomic research
3.2.1.3. Increased focus on precision medicine
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges in data analysis
3.2.2.2. High price of important instruments
3.3. Gene Expression Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Gene Expression Market: Process Estimates & Trend Analysis
4.1. Gene Expression Market: Process Movement Analysis
4.2. Sample Collection
4.2.1. Sample Collection Gene Expression Market, 2021 - 2033
4.3. Purification
4.3.1. Purification Gene Expression Market, 2021 - 2033
4.4. cDNA synthesis & conversion
4.4.1. cDNA synthesis & conversion Gene Expression Market, 2021 - 2033
4.5. PCR Analysis
4.5.1. PCR Analysis Gene Expression Market, 2021 - 2033
Chapter 5. Gene Expression Market: Product Estimates & Trend Analysis
5.1. Gene Expression Market: Product Movement Analysis
5.2. Kits & Reagents
5.2.1. Kits & Reagents Gene Expression Market, 2021 - 2033
5.3. Manufacturing and Packaging
5.3.1. DNA chips Gene Expression Market, 2021 - 2033
5.4. Others
5.4.1. Others Gene Expression Market, 2021 - 2033
Chapter 6. Gene Expression Market: Capacity Estimates & Trend Analysis
6.1. Gene Expression Market: Capacity Movement Analysis
6.2. Low- to Mid- Plex
6.2.1. Low to Mid Plex Expression Market 2021 - 2033
6.3. High-Plex
6.3.1. High-Plex Gene Expression Market 2021 - 2033
Chapter 7. Gene Expression Market: Application Estimates & Trend Analysis
7.1. Gene Expression Market: Application Movement Analysis
7.2. Drug Discovery & Development
7.2.1. Drug Discovery & Development Market 2021 - 2033
7.3. Clinical Diagnostics
7.3.1. Clinical Diagnostics Gene Expression Market 2021 - 2033
7.4. Biotech & Microbiology
7.4.1. Biotech & Microbiology Gene Expression Market 2021 - 2033
7.5. Others
7.5.1. Others Gene Expression Market 2021 - 2033
Chapter 8. Gene Expression Market: Technique Estimates & Trend Analysis
8.1. Gene Expression Market: Technique Movement Analysis
8.2. RNA Expression
8.2.1. RNA Expression Gene Expression Market 2021 - 2033
8.3. Promoter Analysis
8.3.1. Promoter Analysis Gene Expression Market 2021 - 2033
8.4. Protein Expression & Posttranslational Modification Analysis
8.4.1. Protein Expression & Posttranslational Modification Analysis Gene Expression Market 2021 - 2033
8.5. Others
8.5.1. Others Gene Expression Market 2021 - 2033
Chapter 9. Gene Expression Market: Regional Estimates & Trend Analysis
9.1. Gene Expression: Regional Movement Analysis
9.2. North America
9.2.1. Market Gene Expression Market Estimates and Forecast, 2021 - 2033 (Revenue, USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Competitive Scenario
9.2.2.3. Regulatory Framework
9.2.2.4. U.S. Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Competitive Scenario
9.2.3.3. Regulatory Framework
9.2.3.4. Canada Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3. Europe
9.3.1. Europe Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Competitive Scenario
9.3.2.3. Regulatory Framework
9.3.2.4. UK Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Competitive Scenario
9.3.3.3. Regulatory Framework
9.3.3.4. Germany Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Competitive Scenario
9.3.4.3. Regulatory Framework
9.3.4.4. France Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Competitive Scenario
9.3.5.3. Regulatory Framework
9.3.5.4. Italy Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Competitive Scenario
9.3.6.3. Regulatory Framework
9.3.6.4. Spain Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Competitive Scenario
9.3.7.3. Regulatory Framework
9.3.7.4. Denmark Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Competitive Scenario
9.3.8.3. Regulatory Framework
9.3.8.4. Sweden Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Competitive Scenario
9.3.9.3. Regulatory Framework
9.3.9.4. Norway Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.4. Asia Pacific
9.4.1. Asia Pacific Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Competitive Scenario
9.4.2.3. Regulatory Framework
9.4.2.4. Japan Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.4.3. India
9.4.3.1. Key Country Dynamics
9.4.3.2. Competitive Scenario
9.4.3.3. Regulatory Framework
9.4.3.4. India Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Competitive Scenario
9.4.4.3. Regulatory Framework
9.4.4.4. China Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Competitive Scenario
9.4.5.3. Regulatory Framework
9.4.5.4. South Korea Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Competitive Scenario
9.4.6.3. Regulatory Framework
9.4.6.4. Australia Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Competitive Scenario
9.4.7.3. Regulatory Framework
9.4.7.4. Thailand Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.5. Latin America
9.5.1. Latin America Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Competitive Scenario
9.5.2.3. Regulatory Framework
9.5.2.4. Brazil Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Competitive Scenario
9.5.3.3. Regulatory Framework
9.5.3.4. Mexico Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Competitive Scenario
9.5.4.3. Regulatory Framework
9.5.4.4. Argentina Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.6. MEA
9.6.1. MEA Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Competitive Scenario
9.6.2.3. Regulatory Framework
9.6.2.4. South Africa Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Competitive Scenario
9.6.3.3. Regulatory Framework
9.6.3.4. Saudi Arabia Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Competitive Scenario
9.6.4.3. Regulatory Framework
9.6.4.4. UAE Gene Expression Market Estimates and Forecasts, 2021 - 2033
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Competitive Scenario
9.6.5.3. Regulatory Framework
9.6.5.4. Kuwait Gene Expression Market Estimates and Forecasts, 2021 - 2033
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.1.1. Innovators
10.1.2. Market Leaders
10.1.3. Emerging Players
10.1.4. Company Market Share Analysis, 2022
10.2. Company Profiles
10.2.1. Qiagen
10.2.1.1. Company Overview
10.2.1.2. Financial Performance
10.2.1.3. Service Benchmarking
10.2.1.4. Strategic Initiatives
10.2.2. Quest Diagnostics Incorporated
10.2.2.1. Company Overview
10.2.2.2. Financial Performance
10.2.2.3. Service Benchmarking
10.2.2.4. Strategic Initiatives
10.2.3. F. Hoffmann-La Roche Ltd
10.2.3.1. Company Overview
10.2.3.2. Financial Performance
10.2.3.3. Service Benchmarking
10.2.3.4. Strategic Initiatives
10.2.4. Illumina, Inc.
10.2.4.1. Company Overview
10.2.4.2. Financial Performance
10.2.4.3. Service Benchmarking
10.2.4.4. Strategic Initiatives
10.2.5. Bio-Rad Laboratories, Inc.
10.2.5.1. Company Overview
10.2.5.2. Financial Performance
10.2.5.3. Service Benchmarking
10.2.5.4. Strategic Initiatives
10.2.6. Thermo Fisher Scientific, Inc.
10.2.6.1. Company Overview
10.2.6.2. Financial Performance
10.2.6.3. Service Benchmarking
10.2.6.4. Strategic Initiatives
10.2.7. Promega Corporation
10.2.7.1. Company Overview
10.2.7.2. Financial Performance
10.2.7.3. Service Benchmarking
10.2.7.4. Strategic Initiatives
10.2.8. Danaher
10.2.8.1. Company Overview
10.2.8.2. Financial Performance
10.2.8.3. Service Benchmarking
10.2.8.4. Strategic Initiatives
10.2.9. Interpace Diagnostics, LLC.
10.2.9.1. Company Overview
10.2.9.2. Financial Performance
10.2.9.3. Service Benchmarking
10.2.9.4. Strategic Initiatives
10.2.10. Luminex Corporation
10.2.10.1. Company Overview
10.2.10.2. Financial Performance
10.2.10.3. Service Benchmarking
10.2.10.4. Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers